Related Experiment Video
Updated: Jun 11, 2026
09:49
Holistic Facial Composite Creation and Subsequent Video Line-up Eyewitness Identification Paradigm
Published on: December 24, 2015
Insights
The novel HSP90 inhibitor 17-DMAG effectively targets and eliminates chronic lymphocytic leukemia (CLL) cells by inhibiting NF-B. This research presents a promising new therapeutic strategy for treating CLL.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Chronic lymphocytic leukemia (CLL) is a heterogeneous hematologic malignancy.
- Current therapies for CLL have limitations and resistance can develop.
- Targeting key signaling pathways in cancer cells is a crucial therapeutic strategy.
Discussion:
- HSP90 inhibition disrupts multiple oncogenic pathways crucial for CLL cell survival.
- 17-DMAG demonstrates potent and selective cytotoxicity against CLL cells in preclinical models.
- The mechanism involves the targeted inhibition of the NF-B signaling pathway.
Key Insights:
- 17-DMAG exhibits significant anti-leukemic activity in both in vitro and in vivo CLL models.
- Selective targeting of HSP90 by 17-DMAG leads to degradation of client proteins essential for CLL.
- Inhibition of NF-B is a critical mediator of 17-DMAG's therapeutic effect.
Outlook:
- 17-DMAG represents a promising novel therapeutic agent for CLL treatment.
- Further clinical investigation of 17-DMAG in CLL patients is warranted.
- Targeted HSP90 inhibition offers a potential new avenue for overcoming treatment resistance in CLL.
Abstract:
In this issue of Blood, Hertlein and colleagues present compelling in vitro and in vivo evidence that the novel HSP90 inhibitor 17-DMAG is a potent and selective killer of CLL cells that mediates its effects through the targeted inhibition of NF-B. Their findings describe a promising new therapeutic approach for the treatment of this disease.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:17Healthcare Agencies II
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
04:49Robbers Cave
During the 1950s, the landmark Robbers Cave experiment demonstrated that when groups must compete with one another, intergroup conflict, hostility, and even violence may result. At the Oklahoman summer camp, two troops of boys—termed the Rattlers and the Eagles—took part in a week-long tournament. During this time, their negativity culminated in derogatory name-calling, fistfights, and even vandalism and destruction of property. However, this work also revealed that such tension could be...
03:20The Stanford Prison Experiment
The famous and controversial Stanford Prison Experiment, conducted by social psychologist Philip Zimbardo and his colleagues at Stanford University, demonstrated the power of social roles, social norms, and scripts.